Study to evaluate the efficacy and safety of Anakinra in the treatment of articular manifestations refractory to conventional therapy in Systemic Lupus Erythematosus patients
Read time: 1 mins
Last updated:17th Apr 2012
The primary objective of this study is to evaluate the efficacy of Anakinra in patients with SLE and articular manifestations refractory to conventional treatment.
|Study start date||2012-04-17|